Title: The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family
Authors: van der Linden, Lonneke
Vives-Adrián, Laia
Selisko, Barbara
Ferrer-Orta, Cristina
Liu, Xinran
Lanke, Kjerstin
Ulferts, Rachel
De Palma, Armando M
Tanchis, Federica
Goris, Nesya
Lefebvre, David
De Clercq, Kris
Leyssen, Pieter
Lacroix, CĂ©line
Pürstinger, Gerhard
Coutard, Bruno
Canard, Bruno
Boehr, David D
Arnold, Jamie J
Cameron, Craig E
Verdaguer, Nuria
Neyts, Johan
van Kuppeveld, Frank J M # ×
Issue Date: Mar-2015
Publisher: Public Library of Science
Series Title: PLoS Pathogens vol:11 issue:3 pages:e1004733
Article number: 10.1371/journal.ppat.1004733
Abstract: The genus Enterovirus of the family Picornaviridae contains many important human pathogens (e.g., poliovirus, coxsackievirus, rhinovirus, and enterovirus 71) for which no antiviral drugs are available. The viral RNA-dependent RNA polymerase is an attractive target for antiviral therapy. Nucleoside-based inhibitors have broad-spectrum activity but often exhibit off-target effects. Most non-nucleoside inhibitors (NNIs) target surface cavities, which are structurally more flexible than the nucleotide-binding pocket, and hence have a more narrow spectrum of activity and are more prone to resistance development. Here, we report a novel NNI, GPC-N114 (2,2'-[(4-chloro-1,2-phenylene)bis(oxy)]bis(5-nitro-benzonitrile)) with broad-spectrum activity against enteroviruses and cardioviruses (another genus in the picornavirus family). Surprisingly, coxsackievirus B3 (CVB3) and poliovirus displayed a high genetic barrier to resistance against GPC-N114. By contrast, EMCV, a cardiovirus, rapidly acquired resistance due to mutations in 3Dpol. In vitro polymerase activity assays showed that GPC-N114 i) inhibited the elongation activity of recombinant CVB3 and EMCV 3Dpol, (ii) had reduced activity against EMCV 3Dpol with the resistance mutations, and (iii) was most efficient in inhibiting 3Dpol when added before the RNA template-primer duplex. Elucidation of a crystal structure of the inhibitor bound to CVB3 3Dpol confirmed the RNA-binding channel as the target for GPC-N114. Docking studies of the compound into the crystal structures of the compound-resistant EMCV 3Dpol mutants suggested that the resistant phenotype is due to subtle changes that interfere with the binding of GPC-N114 but not of the RNA template-primer. In conclusion, this study presents the first NNI that targets the RNA template channel of the picornavirus polymerase and identifies a new pocket that can be used for the design of broad-spectrum inhibitors. Moreover, this study provides important new insight into the plasticity of picornavirus polymerases at the template binding site.
ISSN: 1553-7366
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Virology and Chemotherapy (Rega Institute)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
2015061.pdfOA article Published 3735KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science